Chesnara (LON:CSN) Sets New 12-Month High – Still a Buy?

Chesnara plc (LON:CSN) shares reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as GBX 352 and last traded at GBX 349.50, with a volume of 1016872 shares trading hands. The stock had previously closed at GBX 339.50.

Chesnara News Summary

Here are the key news stories impacting Chesnara this week:

• Positive Sentiment: HSBC Life acquisition lifts scale and profits: Reports say assets under administration increased by 38% following the deal, while first-half profits were boosted by the acquired business. The transaction appears to be contributing meaningfully to Chesnara’s earnings and strategic scale. Chesnara reports 38% boost in AuA after HSBC Life acquisition Chesnara’s H1 profits surge as results boosted by HSBC deal
• Positive Sentiment: Cash generation strengthens materially: Operating capital generation reportedly approached £100 million, including a 79% year-on-year increase. The improvement strengthens Chesnara’s ability to fund dividends, reduce financial pressure and pursue additional acquisitions. Chesnara’s operating capital generation nears £100m following acquisition Chesnara CEO: 79% jump in capital generation fuels acquisition ambitions
• Positive Sentiment: Dividend increased: Chesnara raised its dividend alongside the stronger results and cash generation, reinforcing the income-investment appeal of the stock. Brokers have reportedly backed the acquisition-driven cash-growth outlook. Chesnara Reports Stronger Cash Generation and Raises Dividend Following HSBC Life Acquisition Chesnara shares climb as brokers back acquisition-driven cash growth
• Positive Sentiment: Underlying product demand remains encouraging: Chesnara reported surging demand for UK onshore bonds, suggesting supportive market conditions for a key area of its business. Chesnara reports surging demand for UK onshore bonds
• Neutral Sentiment: Key issue for investors: Management’s ambitions for further acquisitions could support future growth, but investors will likely monitor integration execution and whether additional deals deliver returns comparable with the HSBC Life transaction.

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank increased their price target on shares of Chesnara from GBX 373 to GBX 404 and gave the company a “buy” rating in a research report on Friday, July 24th. Two equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock has an average rating of “Buy” and an average price target of GBX 382.

Chesnara Trading Up 3.5%

The stock has a 50-day simple moving average of GBX 335.21 and a 200 day simple moving average of GBX 319.55. The company has a current ratio of 2.92, a quick ratio of 38.06 and a debt-to-equity ratio of 49.41. The company has a market cap of £810.91 million, a price-to-earnings ratio of -69.60 and a beta of 0.52.

Chesnara (LON:CSN) last announced its quarterly earnings data on Tuesday, August 25th. The company reported GBX 0.22 earnings per share for the quarter. Chesnara had a negative return on equity of 2.93% and a negative net margin of 1.01%. As a group, equities research analysts predict that Chesnara plc will post 25.3183154 EPS for the current fiscal year.

Chesnara Company Profile

Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers approximately one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.

Following a three-pillar strategy, Chesnara’s primary responsibility is the efficient administration of its customers’ life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests.